August 7, 2020
Gmail users: to ensure you're always viewing the entire newsletter, check at the bottom of the email to see if the newsletter has been "clipped" and click "view entire message" if so.
Member/Center Highlights
Madabhushi named to The Pathologist's 2020 Power List
Last week, The Pathologist released their 2020 Power List which celebrates influential figures, thought leaders and opinion shapers in pathology and laboratory medicine.

For the second year in a row, Anant Madabhushi, PhD, the F. Alex Nason Professor II of Biomedical Engineering, professor of pathology and Director of the Center for Computational Imaging and Personalized Diagnostics at CWRU, was named to the list. Dr. Madabushi is a member of the Case Comprehensive Cancer Center's Cancer Imaging Program and Chair of the Artificial Intelligence in Oncology Symposium Planning Committee. Congratulations, Dr. Madabhushi!
Recommended Reading: Differing Immune-Cell Subsets Underlie Sex Disparities in Glioblastoma
A recent article published in Cancer Discovery (Bayik, 2020, Cancer Discov) highlights disparities in immune system functions between male and female glioblastoma patients that may underlie some of the observed sex differences in cancer incidence, prognosis and treatment response. Defne Bayik, PhD a postdoctoral fellow in Justin Lathia, PhD's lab at Cleveland Clinic Lerner Research Institute, and colleagues from Cleveland Clinic, Case Western Reserve University, University Hospitals, The University of Southern Denmark, Moffitt Cancer Center, and Northwestern University found that monocytic myeloid-derived suppressor cells (MDSC) were enriched in the tumors of male mice, but not female mice. The findings of the work reveal a previously unknown explanation for sex differences in glioblastoma and demonstrates how this knowledge may be therapeutically exploitable. Case Comprehensive Cancer Center members Ahmad Khalil, PhD, Tae Hyun Hwang, PhD, Manmeet Ahluwalia, MD, Feixiong Cheng, PhD, and Justin Lathia, PhD also contributed to the work.
McGinty to Deliver #AIO2020 Plenary Address
This October, Geraldine McGinty, MD, MBA, FACR, Chief Contracting and Strategy Officer and Assistant Professor of Radiology, Health Care Policy and Research at Weill Cornell Medicine will deliver the plenary address of the 2020 Artificial Intelligence in Oncology Symposium. Her talk is titled, "Fostering a Strong Ecosystem for AI in Medical Imaging."

Dr. McGinty is an internationally recognized expert in imaging economics whose published work has focused on payment models for imaging, most recently a bundled payment for breast cancer screening. Recently, she has focused on the impact of Artificial Intelligence on Medical Imaging and has spoken at the Turing Institute and to the WHO Focus Group on AI in Healthcare on this topic.
Geraldine McGinty, MD, MBA, FACR
Additional symposium keynotes on drug discovery, ethics & policy and pathology will be delivered by Russ Altman, MD, PhD of Stanford University, Aashima Gupta, MS of Google, Vinay Prasad, MD, MPH of the University of California, San Francisco, and Yinyin Yuan, PhD of the Institute of Cancer Research, London.
Case CCC COVID-19 Resource Hub
As the COVID-19 outbreak progresses, the Case Comprehensive Cancer Center (Case CCC) has centralized COVID-19 related news, resources and funding opportunities for our cancer center community. Content is updated regularly.

To have a cancer-focused resource added to the page, please email
What's Coming Up
Mark Your Calendar
Early Bird Registration Now Open: Artificial Intelligence in Oncology Symposium 2020
October 19-20, 2020

The second annual Artificial Intelligence in Oncology Symposium will bring together experts in AI and machine learning as well as clinical, industry and federal agency experts in pathology, radiology, drug discovery, and ethics and policy to speak on research developments, regulatory policy, reimbursement and ethics surrounding AI in oncology. For the health and safety of all attendees, this year's symposium will take place virtually.

The symposium will feature four focused sessions, with speakers and panel discussions providing unique perspectives on how AI and machine learning are impacting the major areas of radiology, pathology and -omics in the contexts of precision medicine approaches for characterizing tumors and predicting therapeutic response.

Beyond the science, attendees will be able to network and enjoy a special session highlighting some of the brightest rising stars in the field of AI in oncology, selected from abstract submissions. Submit your abstract by Friday, September 11!

Additional keynotes in drug discovery, ethics & policy and pathology will be delivered by Russ Altman, MD, PhD of Stanford University, Aashima Gupta, MS of Google, Vinay Prasad, MD, MPH of the University of California, San Francisco, and Yinyin Yuan, PhD of the Institute of Cancer Research, London. Learn more about AIO 2020 speakers.
Additional Upcoming Events
Society of Neuro-Oncology Virtual Conference on Brain Metastases
August 14, 2020
The Society for Neuro-Oncology, in association with the AANS/CNS Section on Tumors, is pleased to announce its virtual Conference on Brain Metastases.

This live event will feature select abstract presentations and invited lectures from the originally scheduled in-person meeting which was set to take place in Toronto. Join the exciting and diverse program on August 14, 2020, from 11am - 4pm (US ET).
NCCN Oncology Policy Virtual Summit
September 9, 2020
The Summit will explore diverse perspectives related to emerging models to drive down healthcare costs in the United States and their potential impact on access to high-quality cancer care. Major themes of the summit will include an overview of legislative and regulatory efforts to reduce health costs, the current state of value-based payment models, and the impact of these models on providers and patients with cancer. The summit will also explore the unique implications of policies intended to curb costs for rural and other underserved populations.

If you have any questions, please contact Terrell Johnson, Manager, Policy and Advocacy,
NCCN 2020 Virtual Congress: Hematologic Malignancies
October 9-10, 2020
Attend this NCCN virtual congress to hear from world-renowned experts in the management of Hematologic Malignancies present the latest treatment advances, updates to the standard of care as recommended in the NCCN Guidelines®, and unique and challenging patient cases.

Co-chaired by Ranjana H. Advani, MD, Stanford Cancer Institute, and Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center, this virtual program features presentations and interactive discussions highlighting the treatment options and supportive care for a variety of hematological malignancies.

This program is approved for AMA PRA Category 1 Credit™ for physicians and will award contact hours for nurses, pharmacists, and other health care professionals.
NCCN 2021 Annual Conference: Call for Abstracts
Abstract Deadline: November 11, 2020
NCCN is now accepting abstracts for consideration to be presented during the NCCN 2021 Annual Conference General Poster Session at the Rosen Shingle Creek in Orlando, Florida on Thursday, March 18 and Friday, March 19, 2021. NCCN welcomes original abstracts from investigators in the general oncology community. Submissions will be accepted from academic institutions, teaching and community hospitals, or industry. Both NCCN and non-NCCN institutions may participate.

Research may fall into the general areas below:

  • Clinical Oncology (all phases)
  • Pre-Clinical Oncology
  • Epidemiology/Risks/Prevention
  • Correlative/Genomic
  • Best Practices in Implementation and Use of Clinical Practice Guidelines
  • Quality Improvement
  • Outcomes and Health Services Research
  • Bioinformatics/Information Technology Sciences
Sixth Computational Approaches for Cancer Workshop (CAFCW20)
Abstract Deadline: September 6, 2020
Workshop: November 13, 2020
The National Cancer Institute Center for Biomedical Informatics and Information Technology and SC20 are seeking abstracts for presentations for the Sixth Computational Approaches for Cancer Workshop (CAFCW20). CAFCW20 is a workshop designed to bring together clinicians, cancer biologists, mathematicians, data scientists, computational scientists, engineers, developers, thought leaders, and anyone else interested in advancing computation to use in cancer care and research. This year’s topic is “AI and HPC: Overcoming Data Challenges in Cancer Research and Clinical Applications.”

A special emphasis for the CAFCW20 is the role of HPC and AI to address research challenges when data are limited by availability, variability and size. The workshop will be held in conjunction with SC20: The International Conference on High Performance Computing, Networking, Storage and Analysis in Atlanta, GA., on November 15.
SGO 2021 Annual Meeting
Abstract Deadline: October 23, 2020
Annual Meeting: March 20-23, 2021
The Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer is a comprehensive forum for the subspecialty of gynecologic oncology. Whether you’re a physician, surgeon, researcher, allied health professional or a student in the field, you can join us to make the connections that will boost your career, see what’s new in gynecologic oncology science and research, and learn the best practices and techniques that can take your care to the next level.

The Call for Abstracts and Surgical Films for the SGO 2021 Annual Meeting on Women’s Cancer is open through October 23, 2020. Call for Late-breaking abstracts will be open December 1, 2020 through January 4, 2021.
Funding Opportunities
The Case Comprehensive Cancer Center is now accepting applications for the Fall 2020 pilot funding opportunities:

  • Available award: $75,000 for one year
  • LOI Deadline: August 10, 2020
  • Full Invited Application Deadline: August 31, 2020

  • Available award: $120,000 for one year
  • Deadline: August 31, 2020

  • Available award: $75,000 for 18 months
  • Deadline: August 31, 2020

  • Available award: $180,000 for 18 months
  • Deadline: August 31, 2020

Questions? Contact or Julie DeJager Glavic at 216.368.5780.
LOI Deadline: September 10, 2020
The American Lung Association (ALA) nationwide research program is building on over a century of success as we continue to invest in the brightest, pioneering minds with immense potential to drive innovation, discover the unknown, and improve the lives of those living with lung cancer. The Lung Cancer Discovery Award is for highly meritorious research projects with the potential to:
  • Significantly improve and transform diagnostic and therapeutic paradigms
  • Foster innovation, use novel approaches; and/or
  • Accelerate progress in lung cancer research that improves patient care and helps save lives

This award, for $100,000 per year for up to two years, is intended to support independent investigators conducting clinical, laboratory, epidemiological or any groundbreaking project aimed at revolutionizing our current understanding of lung cancer and improving diagnostic, clinical and treatment methods.
In The News
ideastream - July 29, 2020
Case Western Reserve University researchers are investigating how artificial intelligence (AI) can improve cancer treatments. The technology could possibly cut down on the number of surgeries needed, said lead researchers Pallavi Tiwari, PhD and Satish Viswanath, PhD. Drs. Tiwari and Viswanath are assistant professors of biomedical engineering at Case School of engineering and members of the Case CCC's Cancer Imaging Program.
POPSUGAR - July 30, 2020
"I'm pessimistic that going to bars will be anything less than a high-risk activity for the foreseeable future," said Mark Cameron, PhD, an infectious-disease expert and professor at Case Western Reserve University School of Medicine. Dr. Cameron is a member of the Case CCC's Hematopoietic and Immune Cancer Biology Program.
From The NIH
Save The Date: Fall 2020 NIH Virtual Seminar on Program Funding and Grants Administration
If you’re new to working with the NIH grants process as an investigator or administrator, then mark your calendar for Tuesday, October 27 – Friday, October 30 for a unique opportunity to learn, share and meet virtually with NIH and HHS experts. The NIH is offering a virtual seminar that you won’t want to miss! Below are some highlights of the virtual seminar:

  • Four days of sessions with live and simu-live sessions, as well as an on-demand video library
  • Three tracks designed around grants policies, processes, case-studies and Q&As
  • Live chats one-on-one with NIH & HHS experts on the grants process and policies
  • Downloadable resources to reuse and/or share with others at your institution
  • Registration is free!

Keep tabs on the latest registration and agenda updates, as well as sign up for the LISTSERV, on the NIH Regional Seminar Home Page.
FY2021 NIH SBIR Contract Solicitation
SBIR Contracts are research and development funding opportunities that define specific activities and deliverables that must be met within the award period. This year, National Cancer Institute released 17 topics listed below and on our website. Interested small businesses can submit a proposal through the electronic Contract Proposal Submission (eCPS) website by 5 p.m. EDT on October 26, 2020.
For more information about the FY2021 Contract Solicitation, visit the NCI SBIR current contracts website and join the HHS Contract Opportunity Webinar on Tuesday, August 11, 2020, 1-3 pm EDT.

Receipt Date: October 26, 2020, 5 pm EDT
Informational Webinar: Tuesday, August 11, 2020, 1-3 pm EDT
NCI Topics:

Inquiries: Rosemary Hamill (
Weekly NIH Funding Opportunities and Notices

Funding Opportunities
Deadlines: November 12, 2020; April 9, 2021; November 9, 2021; April 7, 2022; November 9, 2022

Deadline: November 4, 2020

Deadline: November 4, 2020

Deadline: November 4, 2020

Deadline: November 4, 2020

Deadline: November 4, 2020
COVID-19 Funding Opportunities and Notices
Have something to share?
Use the button below to submit all your news, publications, events, announcements, lab openings and communications requests to the Case CCC Marketing and Communications team! We are here to help.